Scientists unlock potential heart attack drug without side effects

March 11, 2014
Scientists unlock potential heart attack drug without side effects

(Medical Xpress)—Melbourne scientists are a step closer to creating a new drug to stop a heart attack in its tracks and reduce the damage caused, without any side effects.

The Monash University research, published today in the journal, Proceedings of the National Academy of Sciences (PNAS), offers new hope to thousands of people who experience attacks and heart failure – one of the major causes of death worldwide.

Professors Arthur Christopoulos and Peter Scammells from the Monash Institute of Pharmaceutical Sciences (MIPS) led a team of scientists combining molecular pharmacology and medicinal chemistry to reveal new insights into a specific protein belonging to the family of G protein-coupled receptors (GPCRs). After successfully combining two molecules, they are a step closer to creating a brand new class of drug that is more targeted and could possess minimal side effects.

GPCRs play a role in virtually every biological process and most diseases, including, cardiovascular disease, obesity and diabetes, neuropsychiatric disorder, inflammation and cancer. Almost half of all current medications available use GPCRs to achieve their therapeutic effect.

Current GPCR drugs work either by fully activating or completely blocking receptors, treating the protein like a simple "on-off" switch. This new research discovered alternative recognition sites on GPCRs that can be targeted by drugs to fine-tune the behavior of the protein, basically converting the "on-off" switch into a "dimmer switch".

Professor Christopoulos said it was this insight that enabled the new breakthrough.

"When a strikes, heart cells die because of a lack of oxygen and nutrients. But even more damage is caused when the blood rushes back to the heart cells due to the release of inflammatory chemicals and damaging free radicals," Professor Christopoulos said.

Currently, drugs to minimise damage to the heart activate the adenosine A1 receptor, a GPCR found in the heart. However, a major issue in activating the A1 receptor also slows down the heart, and too much activation can stop the heart.

"Correct dosage has been a serious challenge in clinical trials for A1 receptor drugs. The consequences are serious; a dosage that is too high can stop the heart from beating. Too low, and the drug fails to prevent cell damage. Getting this balance right has been a big problem," Professor Scammells said.

Professor Christopoulos said the Monash study focused on finding new ways to activate the protein, to achieve the beneficial effects (protection) without the side effects (slowing the heart).

"We turned to our knowledge of alternative recognition sites on the A1 receptor and specifically designed a new class of molecule that contained two active components linked together, one binding to the main site on the receptor for activation, and another binding to the alternative site for fine-tuning of the activity. Our "" strategy worked, resulting in a molecule that protected heart cells but did not affect heart rate at all – at least in our animal models," Professor Christopoulos said.

"The beauty of this protein is that if you activate it effectively, you minimise the heart attack and protect the , and that's something that's never been done before."

The findings will inform the next phase of the research to develop a new drug that could potentially be made available for use by clinicians and emergency paramedics.

Explore further: New discovery in quest for better drugs

More information: Separation of on-target efficacy from adverse effects through rational design of a bitopic adenosine receptor agonist, www.pnas.org/cgi/doi/10.1073/pnas.1320962111

Related Stories

New discovery in quest for better drugs

October 14, 2013
Scientists have combined cutting edge computer modelling with pharmacology and medicinal chemistry to reveal new insights into how the body interacts with novel drug treatments, in research that could lead to the creation ...

Scientists create detailed picture of protein linked to learning, pain and brain disorders

March 6, 2014
Researchers at The Scripps Research Institute (TSRI) and Vanderbilt University have created the most detailed 3-D picture yet of a membrane protein that is linked to learning, memory, anxiety, pain and brain disorders such ...

New blood test could detect heart attacks more quickly

February 25, 2014
A new blood test can detect heart attacks hours faster than the current gold-standard blood test, according to a study led by Loyola University Chicago Stritch School of Medicine researchers.

Researchers announce new advance in body 'chemical switch' study

March 5, 2012
Scientists investigating a 'biochemical switch' linked to strokes and heart disease claim to have made an advance in understanding how it is 'turned on'.

Misplaced protein causes heart failure

March 6, 2014
Colchicine, a drug that's used to treat gout, has the beneficial side effect of lowering the risk of heart attack in patients taking it. Conversely, taxol, a drug for treating cancer, has the opposite effect; raising the ...

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.